Articles
vivoPharm opening for business in the U.S
Adelaide-based contract research organisation vivoPharm has received $US1.3 million to help fund building of the company’s first facility in the U.S. [ + ]
Universal flu vaccine in the offing
Canberra-based biotech Gamma Vaccines reported today that it is ready to start human clinical trials of a universal flu vaccine which it hopes will one day do away with the need for new vaccines to be produced every year while being effective against any pandemic strains. [ + ]
Feature: The science of longevity: Resveratrol and beyond
Sustaining a long, healthy life is the holy grail of medical science. David Sinclair, discoverer of resveratrol, is working on understanding the mechanisms underlying ageing with the hope of producing new drugs that combat diseases and maybe even extend life itself. [ + ]
Ageing, heart disease and colour blindness among key themes for 5th AHMRC
The 5th Australian Health and Medical Research Congress (AHMRC) wound up in Melbourne today after this week playing host to a coterie of top local and international researchers. [ + ]
Call for calm in gene patent debate
Australia’s peak life sciences industry body AusBiotech has called for calm over the escalating debate on gene patenting, which it sees as having been hijacked by ill-informed and emotionally driven political and community groups. [ + ]
Genetics and archaeology combine to identify Europe’s earliest farmers
A team of international researchers led by ancient DNA experts from the University of Adelaide has resolved the longstanding issue of the origins of the people who introduced farming to Europe some 8000 years ago.
[ + ]HealthLinx reports strong results from ovarian cancer study
Shares in diagnostics company HealthLinx surged 18 percent today after the company announced positive results from its independent, multi-centre, multi-site second study for OvPlex based on two new biomarkers being evaluated as diagnostics for ovarian cancer. [ + ]
Out-sniffing bomb-sniffing dogs
A Tel Aviv University researcher has pioneered the development of a swift, small, highly reliable sensor that is claimed to be able to detect explosives more reliably than trained sniffer dogs.
[ + ]Patrys reports positive early stage data from melanoma clinical trial
Shares in Melbourne biotech Patrys jumped by 15 per cent by late morning today after the company announced that it has completed treatment of the first patient group in the melanoma trial of its natural human antibody product PAT-SM6. [ + ]
LCT moves closer to Parkinson’s cure
Living Cell Technologies reported today that its NTCELL cell implant product for neurodegenerative conditions has demonstrated effectiveness in two pre-clinical models of Parkinson's disease. [ + ]
Beta blockers shown to combat osteoporosis
Researchers from Sydney’s Garvan Institute of Medical Research have shown that beta blockers can increase bone density and reduce the risk of osteoporotic fracture in around 50 per cent of patients. [ + ]
New sequencing technology raises questions about existing data
Sequencing technology has advanced so far in the last few years that questions are now being asked about the value of existing research data and the techniques for acquiring it. [ + ]
Feature: The meaning of (artificial) life
It was once widely believed that life differed fundamentally from non-life; the defining characteristic of life was the existence of some insubstantial vital force – an élan vital – for which no physical process could account. [ + ]
Life Research expands portfolio with acquisition of Mimotopes
Life Research has added the peptide portfolio of Mimotopes to its repertoire with the acquisition of the company from its parent, Commonwealth Biotechnologies, by Leadtec Systems. [ + ]
Organic solvent system improves catalyst recycling
A combination of organic solvents in different proportions has been found to differentially dissolve a range of noble metals, making recycling of the metal catalysts easier.
[ + ]